Equally, extracellular HE4 has been shown to enhance proliferation in endometrial cancer cell lines in vitro ([28,29], so HE4 could be a driver of increased tumour aggressiveness, proliferation and resistance to progestogens rather than simply a product of it. This evidence concerns the gene WFDC2 and neoplasm.